|
Nanoparticle-based antibody delivery system to selectively inhibit inflammatory mediators and combat “cytokine storm”.
Recent outbreaks with novel coronaviruses including SARS and MERS as well as the ongoing COVID-19 pandemic underscore existing limitations in managing these deadly pathogens. According to the World Health Organization, there have been over 4.3 million confirmed cases of COVID- 19 and ~300,000 deaths to date. SARS, MERS, and COVID-19 infect the airway...
Published: 3/5/2024
|
Inventor(s): Dobbins Tabbetha, Sreekant Murthy
Keywords(s): Covid-19, Cytokine-storm, Immunology, Inflammation, Respiratory, Therapeutic
Category(s): Human Health Care > Therapeutics
|
